Advertisement
New Zealand markets closed
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NZD/USD

    0.5939
    +0.0002 (+0.03%)
     
  • NZD/EUR

    0.5545
    -0.0001 (-0.02%)
     
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • OIL

    82.82
    +0.01 (+0.01%)
     
  • GOLD

    2,320.70
    -17.70 (-0.76%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    18,088.70
    -48.95 (-0.27%)
     
  • Hang Seng

    17,267.60
    +66.33 (+0.39%)
     
  • NIKKEI 225

    37,776.64
    -683.44 (-1.78%)
     
  • NZD/JPY

    92.2810
    +0.1660 (+0.18%)
     

MDT’s Minimally Invasive Therapies’ Fiscal Q1 2019 Performances

MDT’s Minimally Invasive Therapies’ Fiscal Q1 2019 Performances

In the first quarter of fiscal 2019, Medtronic’s (MDT) Minimally Invasive Therapies Group reported revenue of $2.1 billion compared to $2.5 billion in the fiscal first quarter of 2018, reflecting a ~17% YoY (year-over-year) fall.